Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Glomerulonephritis
How do you counsel patients who are found to have a carrier mutation in a single high-risk APOL1 allele?
Related Questions
Do you modify the albumin level below which you would prophylactically anticoagulate a pregnant patient with nephrotic-range proteinuria, given that hypoalbuminemia is expected in pregnancy?
How would you approach managing an asymptomatic patient with normal kidney function who has elevated p-ANCA and MPO titers along with evidence for pauci-immune glomerulonephritis on kidney biopsy?
How do you address patient concerns regarding the necessity of REMS monitoring when prescribing sparsentan?
How do various therapeutic approaches for IgA nephropathy target the different stages of the four-hit hypothesis?
Under what circumstances would you consider treating with steroid therapy in a patient with HIV-associated nephropathy?
How do you manage nephrotic range proteinuria in a pregnant patient with a known history of diabetic nephropathy prior to pregnancy?
How long would you wait before performing a kidney biopsy in a patient with nephrotic range proteinuria, a negative PLA2R antibody, a negative anti-THSD7A antibody, and stable renal function who recently started treatment a week ago with a DOAC for a pulmonary embolism?
How would you treat idiopathic isolated renal TMA diagnosed on renal biopsy without evidence of MAHA?
Do you use delayed-release budesonide over prednisone or methylprednisolone for the treatment of IgA nephropathy, considering the available safety and efficacy data?
What steroid regimen do you typically use for induction therapy in patients with lupus nephritis?
